Fenofibrate Reduces the Risk of Amputations in Patients With Type 2 Diabetes
Rome (ots/PRNewswire) - - Exciting New Data From the FIELD Study Show Additional Microvascular-Associated Benefits of Fenofibrate - The First Time in a Large-Scale Prospective Study That any Lipid-Modifying Therapy has Been Shown to Significantly Reduce the Risk of Lower-Limb Amputation in Patients With Type 2 Diabetes Fenofibrate treatment in people ...
mehr